Orakl Oncology
Orakl Oncology

Orakl Oncology

Measured by AhrefsDR30 out of 100, Below median. Ahrefs DR. Open the scores section.Ahrefs DR: 30/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent42 out of 100, Above median. Agent Readiness. Open the scores section.Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Measured by StartupHub.aiTrust69 out of 100, Above median. Data Trust. Open the scores section.Data Trust: 69/100. Above median. Measured by StartupHub.ai. Median 61.

Orakl Oncology builds AI-powered virtual cancer patients to test drugs and predict their efficiency before clinical trials.

Active44Paris, France

About

Orakl Oncology builds AI-powered virtual cancer patients to test drugs and predict their efficiency before clinical trials. Orakl Oncology is a Paris-based biotechnology startup building AI-powered virtual cancer patients to test drugs and predict their efficiency before they reach clinical trials.

Key facts

Website
orakl-oncology.com
Headquarters
Paris, France
Employees
44
Total funding
$34M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by Orakl Oncology
DateRoundAmountLead investors
12 Nov 2026Series A$34MNorrsken VC, Singular

Tech stack

Detected on orakl-oncology.com, last scanned 12 Nov 2026.

Frontend
Nuxt
CDN
Cloudflare
Email provider
Microsoft 365
Run your own scan

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

Is Orakl Oncology trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Orakl Oncology is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Orakl Oncology raised?

Orakl Oncology has raised a total of $34M in funding. The most recent round on record is Series A.

How many employees does Orakl Oncology have?

Orakl Oncology has approximately 44 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for Orakl Oncology:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules